Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announced technical ...
DexCom (NasdaqGS:DXCM) has launched Dexcom Flex, a new continuous glucose monitoring system for Type 2 diabetes patients who ...
During Dexcom Investor Day, CEO Jake Leach announced the company's newest CGM monitor, G8, which utilizes technology that ...
Dexcom (DXCM) is leveraging AI to drive operational efficiency and product innovation, positioning itself as a platform ...
Zacks Investment Research on MSN
DXCM to launch Dexcom Flex CGM system for type 2 diabetes in Germany
DexCom DXCM recently announced the launch of Dexcom Flex, a new continuous glucose monitoring (CGM) system designed for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Glucose-monitoring specialist Dexcom announced it has made a $75 million strategic investment in health-tracking ring maker Oura and established a strategic partnership to enable two-way data flow ...
Dexcom, the locally based maker of continuous glucose monitors for diabetes patients, is projecting billion-dollar growth into 2030, and San Diego stands to profit. The medtech company invested more ...
Activist investor Elliott Investment Management has taken a stake in medical device firm Dexcom Inc. and struck a settlement ...
Dexcom shares plunged on disappointing revenue and weak guidance. The stock was down 13% for the year as of Thursday's close. Dexcom makes continuous glucose monitors for patients with diabetes. In ...
DexCom's improved fundamentals and a 15% lower stock price present a more attractive entry. Learn why DXCM stock is a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results